Related references
Note: Only part of the references are listed.The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy
Jia Liu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Protective effects of hesperidin on oxidative stress, dyslipidaemia and histological changes in iron-induced hepatic and renal toxicity in rats
Leelavinothan Pari et al.
TOXICOLOGY REPORTS (2015)
Obesity Alters Adipose Tissue Macrophage Iron Content and Tissue Iron Distribution
Jeb S. Orr et al.
DIABETES (2014)
Antifibrotic activity of hesperidin against dimethylnitrosamine-induced liver fibrosis in rats
Shimaa M. Elshazly et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Hesperidin Prevents Liver Fibrosis in Rats by Decreasing the Expression of Nuclear Factor-κB, Transforming Growth Factor-β and Connective Tissue Growth Factor
J. Eliuth Perez-Vargas et al.
PHARMACOLOGY (2014)
Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
Akinobu Takaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome
Takeshi Nishida et al.
LABORATORY INVESTIGATION (2013)
Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury
Terrence C. H. Tan et al.
LABORATORY INVESTIGATION (2013)
Liver-spleen axis: Intersection between immunity, infections and metabolism
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in rats
Leelavinothan Pari et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2012)
Relationship Between the Pattern of Hepatic Iron Deposition and Histological Severity in Nonalcoholic Fatty Liver Disease
James E. Nelson et al.
HEPATOLOGY (2011)
Effects of Hesperidin on the Progression of Hypercholesterolemia and Fatty Liver Induced by High-Cholesterol Diet in Rats
Xinhui Wang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT
Luca Valenti et al.
GASTROENTEROLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis
Kaori Suzuki et al.
HEPATOLOGY RESEARCH (2010)
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Giovanni Tarantino et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Hesperidin a flavanoglycone protects against γ-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats
Kannampalli Pradeep et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death
Nese Imeryuz et al.
JOURNAL OF HEPATOLOGY (2007)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?
S Chitturi et al.
HEPATOLOGY (2002)
HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity
S Chitturi et al.
HEPATOLOGY (2002)
Update on nonalcoholic fatty liver disease
AJ McCullough
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Spleen enlargement in patients with nonalcoholic fatty liver - Correlation between degree of fatty infiltration in liver and size of spleen
Y Tsushima et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Share Paper
